Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucosal adjuvants.

L C Freytag1, J D Clements

  • 1Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, LA 70112, USA.

Vaccine
|March 1, 2005
PubMed
Summary
This summary is machine-generated.

Oral immunization requires adjuvants to stimulate immunity. Bacterial products like enterotoxins, CpG ODN, and MPL show promise as mucosal adjuvants by interacting with various immune cells and pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4<sup>+</sup> T cells following parenteral immunization.

Mucosal immunology·2017
Same author

Mucosal immune responses induced by transcutaneous vaccines.

Current topics in microbiology and immunology·2012
Same author

Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.

Clinical and vaccine immunology : CVI·2012
Same author

Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae.

Mucosal immunology·2011
Same author

Use of nanocarriers for transdermal vaccine delivery.

Clinical pharmacology and therapeutics·2007
Same author

Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G).

Medical mycology·2002
Same journal

V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023.

Vaccine·2026
Same journal

In silico selection and in vivo evaluation of scoloptoxin SSD14, Rm-inositol monophosphatase, and Rm-neprilysin as potential anti-tick vaccines.

Vaccine·2026
Same journal

Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults.

Vaccine·2026
Same journal

Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girls.

Vaccine·2026
Same journal

Public health benefits of maternal influenza vaccination among pregnant women and infants <6 months in the United States, 2011-2020.

Vaccine·2026
Same journal

Effectiveness and acceptability of an opt-out nudge to promote influenza vaccination among medical residents: A randomized controlled trial.

Vaccine·2026
See all related articles

Area of Science:

  • Immunology
  • Microbiology

Background:

  • Oral immunization efficacy often relies on adjuvants to bridge innate and adaptive immunity.
  • Bacterial products, including ADP-ribosylating enterotoxins, CpG ODN, and MPL, are key candidates for mucosal adjuvants.

Purpose of the Study:

  • To elucidate the mechanisms of action for potent mucosal adjuvants.
  • To explore potential synergistic effects of these adjuvants, particularly with plant-derived vaccines.

Main Methods:

  • Review of existing literature on the mechanisms of ADP-ribosylating enterotoxins, CpG ODN, and MPL.
  • Discussion of cellular interactions (epithelial cells, immune cells) and signaling pathways (MyD88-dependent/independent).

Main Results:

  • Adjuvanticity of enterotoxins is proposed as an outcome of interaction with multiple cell types.

Related Experiment Videos

  • CpG ODN and MPL exhibit diverse effects on innate and adaptive immunity via MyD88-dependent and -independent pathways.

    • Conclusions:

    • Understanding adjuvant mechanisms is crucial for optimizing oral vaccine strategies.
    • Synergy between different mucosal adjuvants may enhance vaccine potency, especially in conjunction with novel vaccine platforms like plant-derived vaccines.